Nox4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NOX4 (NADPH Oxidase 4) is a gene located on chromosome 11q14.3 that encodes NADPH oxidase 4, a constitutively active member of the NADPH oxidase (NOX) family of enzymes[1]. Unlike other NOX isoforms that primarily produce superoxide anion (O₂⁻), NOX4 predominantly generates hydrogen peroxide (H₂O₂), which has distinct signaling properties and cellular effects.
NOX4 has complex and context-dependent roles in neurodegeneration. It is expressed in neurons, astrocytes, microglia, and endothelial cells within the brain, where it contributes to both physiological signaling and pathological processes[2]. Its constitutive activity and H₂O₂ production make it unique among NOX enzymes.
| NADPH Oxidase 4 | |
|---|---|
| Gene Symbol | NOX4 |
| Full Name | NADPH Oxidase 4 |
| Chromosome | 11q14.3 |
| NCBI Gene ID | [50507](https://www.ncbi.nlm.nih.gov/gene/50507) |
| OMIM | 605966 |
| Ensembl ID | ENSG00000188882 |
| UniProt ID | [Q9NPH5](https://www.uniprot.org/uniprot/Q9NPH5) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Diabetic Neuropathy, Stroke |
NOX4 encodes a protein of approximately 578 amino acids with a molecular weight of ~67 kDa. The protein architecture differs from other NOX isoforms:
NOX4 generates H₂O₂ through a two-step process:
NADPH → FAD → heme → O₂ → O₂⁻ → SOD → H₂O₂
In the central nervous system, NOX4 is expressed in:
NOX4 has dual, context-dependent roles in AD[3]:
Potentially Beneficial Effects:
Potentially Harmful Effects:
The balance between these effects likely depends on NOX4 expression levels, cellular context, and disease stage[4].
In PD, NOX4 generally promotes pathology[5]:
NOX4 is strongly upregulated following ischemic injury:
NOX4 plays a key role in diabetic complications:
| Stimulus | Effect | Mechanism |
|---|---|---|
| Hypoxia | ↑↑↑ | HIF-1α dependent |
| TGF-β | ↑ | SMAD signaling |
| Hyperglycemia | ↑ | PKC activation |
| Inflammatory cytokines | ↑ | NF-κB dependent |
| Shear stress | ↑ | MAPK pathways |
| Compound | Specificity | Development Stage |
|---|---|---|
| GKT137831 | NOX1/NOX4 | Phase 2 (diabetic nephropathy) |
| GKT831 | NOX1/NOX4 | Phase 2 (IPF) |
| VAS2870 | Pan-NOX | Preclinical |
NOX4 activity can be assessed through:
The study of Nox4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Bedard & Krause, The NOX family of ROS-generating NADPH oxidases (2007). Physiol Rev. 2007. ↩︎
Sorce & Krause, NOX enzymes in the central nervous system (2009). J Neurochem. 2009. ↩︎
Park et al. NOX4 in Alzheimer's disease (2014). Neurobiol Aging. 2014. ↩︎
Hu et al. Dual role of NOX4 in neurodegeneration (2015). Free Radic Biol Med. 2015. ↩︎
Sato et al. NOX4 in Parkinson's disease (2014). Neuroscience. 2014. ↩︎